The performance of traditional Chinese medicine injection enterprises has gone up and down, and the industry adjustment is continuing

[market analysis of chinapharma.com] Traditional Chinese medicine injection is a preparation for subcutaneous, muscular and intravenous injection, which is made by extracting, refining and compounding drugs It is a combination of traditional medicine theory and modern production process, and it also breaks through the traditional way of Chinese medicine delivery When it comes to traditional Chinese medicine injection, we have to say the adverse reactions The causes of adverse reactions are various, which are related to the injection itself, the operation methods of medical staff, as well as the physique of the recipient According to the relevant data, in the reports of adverse reactions and events of traditional Chinese medicine, more than 50% of the drugs were given intravenously, while 80% of the drugs reported serious adverse reactions were given intravenously In 2006, the "Houttuynia injection incident" shocked the industry Because of the frequent occurrence of serious adverse events caused by Houttuynia cordata, the risk of traditional Chinese medicine injection is also known to the public Why is the high adverse reaction rate of traditional Chinese medicine injection? Although there are different arguments, the high data of adverse reactions and events of traditional Chinese medicine injection is not only the problem of traditional Chinese medicine injection itself, but also the problem of irregular use and abuse According to the relevant media reports, at present, the sales scale of traditional Chinese medicine injection is about 80 billion yuan, and there are a lot of abuse behaviors And these abuses enlarge the risk of traditional Chinese medicine injection and push it to the abyss Although there are many problems in the traditional Chinese medicine injection industry, relevant data show that the compound growth rate of traditional Chinese medicine injection in recent years is still considerable Although it has declined, it is still higher than the income growth rate of traditional Chinese medicine and the whole drug market In recent years, the achievements of traditional Chinese medicine injection enterprises have also been published The author has learned that HongRi pharmaceutical has published the 2018 half year report According to the half year report, the company has realized operating revenue of 1.96 billion yuan, a year-on-year increase of 36.04%; operating profit of 395.4653 million yuan, a year-on-year increase of 18.85%; total profit of 414.3481 million yuan, a year-on-year increase of 25.16%; net profit attributable to shareholders of listed companies of 345.519 million yuan, a year-on-year increase of 22.35% In addition to HongRi pharmaceutical, another pharmaceutical company in the traditional Chinese medicine injection industry, Shenwei pharmaceutical also recently released a positive profit announcement As of June 30, 2018, the owner of Shenwei pharmaceutical is expected to account for an increase of about 40% over the same period last year However, for the growth of performance in the first half of the year, Shenwei pharmaceutical said that it was not only from traditional Chinese medicine injection, but also oral preparation products and traditional Chinese medicine formula granules Some companies have seen their performance rise, while others have seen their performance decline Dali pharmaceutical's net profit attributable to the shareholders of the listed company is 885800 yuan, down 97.16% compared with the same period of last year; Kunming Pharmaceutical Group's net profit attributable to the shareholders of the listed company is 181 million yuan, down 16.2% compared with the same period of last year In the view of insiders, the adjustment of traditional Chinese medicine injection industry is still continuing Since this year, the State Food and drug administration has announced the revision of the instructions for several traditional Chinese medicine injections According to the regulations of the standards for the examination and approval of prescriptions in medical institutions, traditional Chinese medicine injections need to be prescribed separately, and will face greater examination in the future Under the pressure of complex parties, the State Food and drug administration has been trying to shrink the unsafe traditional Chinese medicine injection industry in a slow way The industry believes that the traditional Chinese medicine injection has formed a huge industrial chain, relying on the traditional Chinese medicine industry, followed by "traditional Chinese medicine culture", and under the policy of encouraging the development of traditional Chinese medicine, the social impact of the direct cut-off by supervision cannot be underestimated In addition, the industry has also predicted that the decline trend of related performance of traditional Chinese medicine injection enterprises will remain unchanged, and it may take several years for traditional Chinese medicine injection to really exit the market.